The present invention relates generally to apparatus and methods for sealing punctures in a body, and more particularly, to apparatus and methods for sealing a vascular puncture extending through tissue into a blood vessel, and to apparatus and methods for delivering a plug, sealant, and/or other material into a percutaneous puncture extending from a patient's skin to a blood vessel or other body lumen, e.g., to seal the puncture.
Apparatus and methods are known for accessing a patient's vasculature percutaneously, e.g., to perform a procedure within the vasculature, and for sealing the puncture that results after completing the procedure. For example, a hollow needle may be inserted through a patient's skin and overlying tissue into a blood vessel. A guide wire may be passed through the needle lumen into the blood vessel, whereupon the needle may be removed. An introducer sheath may then be advanced over the guide wire into the vessel, e.g., in conjunction with or subsequent to one or more dilators.
A catheter or other device may be advanced through the introducer sheath and over the guide wire into a position for performing a medical procedure. Thus, the introducer sheath may facilitate accessing and/or introducing various devices into the vessel, while minimizing trauma to the vessel wall and/or minimizing blood loss. Upon completing the procedure, the device(s) and introducer sheath may be removed, leaving a puncture extending between the skin and the vessel wall.
To seal the puncture, external pressure may be applied to the overlying tissue, e.g., manually and/or using sandbags, until hemostasis occurs. This procedure, however, may be time consuming and expensive, requiring as much as an hour of a medical professional's time. It is also uncomfortable for the patient, and may require the patient to remain immobilized in the operating room, catheter lab, or holding area. In addition, a risk of hematoma exists from bleeding before hemostasis occurs.
Various apparatus and methods have been suggested for sealing a percutaneous puncture instead of using external pressure. For example, U.S. Pat. No. 5,108,421 to Fowler discloses a plug that may be delivered into a puncture through tissue. U.S. Pat. Nos. 5,192,302 and 5,222,974 issued to Kensey et al. describe a bioabsorbable collagen plug that may be delivered through an introducer sheath into a puncture site. The disclosed plug, however, may be difficult to position properly with respect to the vessel, which may be significant since it is generally undesirable to expose the collagen material within the bloodstream where it may float downstream and cause an embolism.
U.S. Pat. No. 6,605,294 describes rods, plugs, and crushed or irregularly shaped pieces of substantially dehydrated hydrogel that may be introduced into a lumen or void in a patient's body, e.g., to seal or plug a biopsy needle track, reinforce weak tissue, or deliver a therapeutic compound. In one embodiment, a plug of dehydrated hydrogel may be deployed into the site of an arteriotomy and allowed to hydrate in the presence of the tissue fluids and blood, to fill the tract of the catheter sheath and prevent further bleeding. By swelling to equilibrium hydration, the plug may lock itself firmly in place and thus reduce the risk of formation of a large hematoma at the site of the puncture.
U.S. Pat. No. 6,703,047 discloses dehydrated hydrogel precursor-based, tissue adherent compositions. The hydrogels may be used, for example, for sealing fluid leaks from tissue, as adherent drug delivery depots, and as means for augmenting and/or supporting tissue. The hydrogels may be administered directly to an open wound site or may be dispensed, e.g., using a non-adhesive backing material, an absorbable backing material, a syringe applicator, a powder atomization or aerosolization system, or a needle-less injector.
The present invention is directed to apparatus and methods for sealing a puncture in a body, and, more particularly, to apparatus and methods for providing temporary or permanent hemostasis within a vascular puncture extending into a blood vessel, and/or to apparatus and methods for delivering a sealant and/or other material into a percutaneous puncture extending from a patient's skin to a blood vessel or other body lumen.
In accordance with one embodiment, an apparatus is provided for sealing a puncture extending through tissue that includes an introducer sheath including a distal end sized to be introduced in a puncture, and a cartridge or other tubular member including a proximal end, a distal end sized for insertion into the introducer sheath, a lumen extending between the tubular member proximal and distal ends, and a distal opening in communication with the lumen. The apparatus includes a locking element for engaging a portion of the introducer sheath to the tubular member to couple subsequent movement of the introducer sheath to the tubular member, e.g., once the tubular member distal end enters the introducer sheath. A sealant may be disposed within the tubular member, e.g., within the lumen adjacent the distal opening, and a pusher member may be disposed within the lumen for deploying the sealant from the tubular member, e.g., out the distal opening into a puncture or other passage through tissue.
Optionally, the introducer sheath may include an abutment or other feature on its proximal end for engaging the locking element when the tubular member is advanced into the introducer sheath. Alternatively, the introducer sheath may include one or more seals on the proximal end and/or a hub on the proximal end that engage with the locking element when the tubular member is advanced into the introducer sheath.
In one embodiment, the locking element may include a coil carried by the tubular member. One or more windings of the coil may engage the introducer sheath, e.g., the abutment, seal(s), hub, or other features on the introducer sheath, when the tubular member is advanced into the introducer sheath, coupling subsequent movement of the introducer sheath to the tubular member. Such coupling may prevent the sealant from being prematurely deployed from the tubular member, e.g., within the introducer sheath, by coupling retraction of the introducer sheath and tubular member, as described further elsewhere herein.
In another embodiment, the locking element may include one or more prongs, fingers, or other detents that engage the abutment, seal(s), hub, or other features on the introducer sheath. The prongs may be compressed by the introducer sheath to a compressed position, but may expand to an expanded position when advanced distally beyond the abutment, seal(s), hub, or other features. Subsequent proximal movement of the tubular member causes the prongs to engage the features on the introducer sheath, thereby retracting the introducer sheath together with the tubular member, i.e., limiting subsequent proximal movement of the tubular member separate from the introducer sheath. Optionally, the prongs may be provided on a sleeve disposed over the tubular member or between the tubular member and the introducer sheath. For example, the sleeve may be free to “float” on a catheter or other elongate positioning member received through the tubular member and introducer sheath. At least a portion of the sleeve may have a diameter larger than a lumen of the introducer sheath, such that the distance the prongs are inserted into the introducer sheath is limited when the sleeve contacts the proximal end of the introducer sheath.
In another embodiment, the locking element may include an assembly with an expandable tube coupled to a locking hub through which the tubular member may be received. The assembly may be received in the lumen of the introducer sheath, e.g., such that the expandable tube is inserted at least partially into the hub or proximal end of the introducer sheath, e.g., distally beyond the abutment, seal(s), or other feature(s). Subsequently, when the tubular member is advanced through the expandable tube, the tube is directed to an expanded position, such that subsequent proximal retraction of the tubular member causes the expandable tube to engage the feature(s) on the introducer sheath. Thus, the introducer sheath becomes coupled to the tubular member, thereby limiting subsequent movement of the tubular member separate from the introducer sheath.
The diameter of the locking hub may be greater than that of the lumen of the introducer sheath, such that the locking hub limits advancing the expandable tube into the introducer sheath, e.g., when the locking hub contacts the proximal end of the introducer sheath. Optionally, the locking hub may receive one or more barbs, tabs, or other detents on the tubular member, e.g., on a handle portion of the tubular member for coupling the locking hub and expandable tube to the tubular member. When the locking hub receives the detent(s), the locking hub may prevent subsequent withdrawal of the detent(s), thereby coupling the introducer sheath to the tubular member via the locking element and/or preventing the sealant from being deployed from the tubular member into the introducer sheath.
In still another embodiment, the locking element may include a bellows or compressible sleeve, e.g., that may be disposed around the cartridge. When the cartridge is advanced into the introducer sheath, the bellows may at least partially enter the introducer sheath and become compressed and/or expanded to engage one or more features within the introducer sheath to couple subsequent movement of the introducer sheath to the cartridge. Optionally, the bellows may include a handle or other safety feature, e.g., on a proximal end of the bellows, that may be pulled to extend and/or collapse the bellows if it is desired to disengage the introducer sheath from the cartridge.
The sealant may include a variety of materials, such as dried or freeze-dried hydrogel material, which may hydrate and/or otherwise expand when exposed to an aqueous physiological environment. In exemplary embodiments, the sealant may include a plug or core, e.g., of freeze-dried hydrogel, and a coating on at least a portion of the core, e.g., including one or more precursors, which may remain in an unreactive state until exposed to an aqueous physiological environment, whereupon the precursor(s) may react, e.g., to form an adherent coating on the core. Optionally, an activating agent, e.g., a pH adjusting material, may be disposed on at least a portion of the core, the activating agent facilitating or initiating reaction of the first and second precursors when exposed to an aqueous physiological environment.
In accordance with another embodiment, an apparatus is provided for sealing a puncture extending through tissue and communicating with a body lumen that includes an introducer sheath including a proximal end, a distal end sized for introduction into a puncture or other passage through tissue, and a lumen extending between the proximal and distal ends, and a cartridge or other tubular member including a proximal end, a distal end sized for insertion into the introducer sheath, a lumen extending between the proximal and distal ends, and a locking element for coupling the introducer sheath to the tubular member. A sealant may be disposed within the lumen of the tubular member, e.g., adjacent the distal end, and a pusher member may be disposed within the tubular member lumen for deploying the sealant from the tubular member.
The pusher member and sealant may include a lumen extending therethrough, and the apparatus may include an elongate positioning member including a proximal end slidable through the sealant lumen and the pusher member lumen. The positioning member may include an expandable positioning element on a distal end thereof for preventing the positioning element from being removed from the body lumen into the puncture after being deployed within the body lumen and/or for sealing the body lumen from the puncture.
In accordance with still another embodiment, a method is provided for sealing a puncture extending through tissue to a body lumen. A positioning member may be introduced into the puncture through an introducer sheath until a positioning element thereon is exposed within the body lumen, the positioning element may be expanded, and the positioning member may be retracted until the expanded positioning element contacts a wall of the body lumen. A cartridge or other tubular member carrying a sealant is introduced through the introducer sheath and over the positioning member until the sealant is disposed proximate the positioning element.
When the tubular member is introduced into the introducer sheath, the introducer sheath is coupled to the tubular member. The tubular member is then retracted relative to the sealant to expose the sealant within the puncture, e.g., adjacent the body lumen. Because the introducer sheath is coupled to the tubular member, retraction of the tubular member automatically withdraws the introducer sheath from the puncture, thereby exposing the sealant within the puncture beyond the introducer sheath. Optionally, the sealant may be cinched or otherwise compressed within the puncture, e.g., using a pusher member also carried within the tubular member.
When the sealant is exposed to bodily fluid when the tubular member is retracted, the sealant may hydrate and/or expand to enhance sealing the puncture. The positioning element may be collapsed and the positioning member may be withdrawn from the body lumen and puncture, e.g., while the pusher member prevents substantial migration of the sealant. Finally, the pusher member may be removed, leaving the sealant within the puncture to achieve hemostasis.
Other aspects and features of the present invention will become apparent from consideration of the following description taken in conjunction with the accompanying drawings.
Turning to the drawings,
As best seen in
The introducer sheath 20 may be formed using known materials and/or methods, e.g., plastic with the tubular body and hub 23 substantially permanently connected together, e.g., using an interference fit, one or more mating connectors (not shown), bonding with adhesive, sonic welding, and the like. The hub 23 generally includes one or more seals (not shown) adjacent an opening 27, which may prevent flow of blood or other fluids out of the hub 23 from the lumen 26, yet accommodate insertion of one or more instruments into the lumen 26, such as the cartridge 120. Optionally, as shown, the hub 23 may include a side port 29 communicating with the lumen 26, e.g., for coupling a source of saline or other fluid (not shown) to the hub 23.
The hub 23 also includes one or more abutments 28 therein, e.g., adjacent opening 27. For example, the hub 23 may include one or more annular ridges, tabs, grooves, lips and the like, which may provide abutment(s) 28 for interlocking or otherwise engaging with the locking element 150, as described elsewhere herein. Alternatively, the seal(s) within the hub may provide sufficient abutment for engaging with the locking element 150, thereby obviating the need for separate ridges or grooves.
With additional reference to
Additionally, as shown in
With further reference to
The pusher member 130 may be substantially rigid, semi-rigid, and/or substantially flexible, having sufficient column strength to allow proximal movement of the cartridge 120 relative to the sealant 2 without buckling the pusher member 130 and/or to allow the distal end 134 of the pusher member 130 to be “tamped” down on sealant 2 within a puncture, e.g., by pushing from the proximal end 132, as described elsewhere herein. The pusher member 130 may also include a lumen 136 extending between the proximal and distal ends 132, 134, e.g., to accommodate the positioning member 140, a guidewire (not shown), a flowable sealing compound, and/or fluid.
As shown in
The sealant 2 may be disposed within the lumen 126 of the cartridge 120 proximate to the distal end 124, e.g., immediately adjacent the distal tip 125. The lumen 126 may be sized such that the cartridge and sealant 2 are slidable relative to one another, e.g., to allow the cartridge 120 to be retracted proximally relative to the sealant 2 and/or pusher member 130.
Optionally, as shown in
With continued reference to
For example, as shown in
Alternatively, the positioning element may be biased to an enlarged condition, but may be compressed to a contracted condition, e.g., by an overlying sleeve or other constraint (not shown). The constraint may be removed to expose the positioning element, allowing the expandable element to automatically expand to the enlarged condition. Additional information on expandable structures that may be provided on the positioning member 140 may be found in U.S. Pat. Nos. 6,238,412, 6,635,068, and 6,890.343, and in co-pending application Ser. No. 10/975,205, filed Oct. 27, 2004. The entire disclosures of these references are expressly incorporated herein by reference.
Returning to
The sealant 2 may be substantially homogeneous, or may include one or more different materials at one or more locations. For example, in one embodiment, the sealant 2 may include a carrier or core having first and second hydrogel precursors disposed thereon in an unreactive state, which may provide an adherent coating when the sealant 26 is exposed to an aqueous environment. In one embodiment, the sealant 2 may be formed from a biocompatible and/or bioabsorbable hydrogel, e.g., polyethylene glycol (“PEG”), or other synthetic material. For example, the hydrogel may include a lyophilized (i.e., freeze-dried) PEG polymer that includes hydrolytically degradable chemical groups, e.g., including a macroporous polymer network, which may uptake fluid and expand when exposed to an aqueous environment. The magnitude of expansion or swelling (pre to post hydration) may be significant, e.g., between about two and ten times (2×-10×) its lyophilized size based on volume.
In addition or alternatively, the sealant 2 may include pro-thrombotic material, e.g., including one or more biological pro-thrombotics, such as collagen, fibrin, carboxymethylcellulose, oxidized cellulose, alginates, gelatin, or other protein-based material, and/or synthetic materials, such as polyglycolic acids (PGA's), polyactides (PLA's), polyvinyl alcohol, and the like. Optionally, the sealant 2 may include one or more therapeutic and/or pharmaceutical agents, e.g., to promote healing, prevent infection and/or other adverse medical events, and the like. Such agents may be embedded in the sealant material and/or applied as one or more coatings or layers. Exemplary materials and methods for making and using them are disclosed in U.S. Pat. Nos. 6,152,943, 6,165,201, 6,179,862, 6,514,534, 6,379,373, 6,703,047, and in co-pending application Ser. No. 10/010,715 filed Nov. 9, 2001, Ser. No. 10/068,807 filed Feb. 5, 2002, Ser. No. 10/454,362, filed Jun. 4, 2003, published as US 2004/0249342, Ser. No. 10/982,387, filed Nov. 5, 2004, published as US 2006/0034930, Ser. No. 10/982,384, filed Nov. 5, 2004, published as US 2006/0099238, and Ser. No. 11/465,791, filed Aug. 18, 2006. The disclosures of these references are expressly incorporated by reference herein.
Turning to
Optionally, the positioning member 140 and/or pusher member 130 may include one or more elements that engage when the cartridge 120 reaches a predetermined location when advanced along the positioning member 140, e.g., to limit subsequent proximal movement of the pusher member 130 relative to the positioning member 140. For example, as shown in
The reduced region 145 may be provided at a predetermined location on the positioning member 140, e.g., a predetermined distance from the positioning element 146 that corresponds to a length of the pusher member 130. As the cartridge 120 (and consequently the pusher member 130) is advanced over the positioning member 140, e.g., until the sealant 2 is disposed adjacent the positioning element 146, the element 137 may pass freely over the reduced region 145. Thereafter, the element 137 may prevent the pusher member 130 from being retracted again past the reduced region 145, due to the blunt edge of the element 137 abutting the abrupt transition of the reduced region 145.
Alternatively, the cartridge member 120 and pusher member 130 may be provided initially adjacent the distal end 144 of the positioning member 140, as shown in
With additional reference to
As shown in
When the introducer sheath 20 and the cartridge 120 are coupled by the coil 150a in this manner, the cartridge 120 may still be advanced distally through the coil 150a and further into the introducer sheath 120. Additionally, the diameter of the hub 123 may be greater than the diameter of the coil 150a, such that the hub 123 compresses the coil 150a as the cartridge 120 is advanced distally into the introducer sheath 120, as shown in
The coil 150a may allow the cartridge 120 to be engaged with introducer sheaths having different lengths. For example, as shown in
Thereafter, when the cartridge 120 is retracted proximally, the leading end 152 of the coil 150a may engage the abutment(s) 28, thereby pulling the introducer sheath 20 proximally with the cartridge 120. The windings of the leading end 152 distally beyond the abutment(s) 28 may have sufficient rigidity to allow the introducer sheath 20 to be pulled proximally, and/or may be supported by the proximal windings 154 compressed against the abutment(s) 28, as shown in
Turning to
In an exemplary method, the puncture 90 may be created using known procedures, e.g., using a needle, guidewire, one or more dilators, and the like (not shown). An introducer sheath 20 may be advanced through the puncture 90 into the vessel 94, e.g., over a guide wire placed through the puncture 90 into the vessel 94. The introducer sheath 20 may provide access into the vessel 92 for one or more instruments, e.g., to allow one or more diagnostic and/or interventional procedures to be performed via the vessel 92. Upon completing the procedure(s) via the vessel 94, any such instrument(s) may be removed from the puncture 90, leaving the introducer sheath 20 extending through the puncture 90 into the vessel 94.
With reference to
Still referring to
In an exemplary method, this may involve a two-step process (although it may be completed in a single continuous action). First, with the positioning element 146 expanded within the vessel 94, the positioning member 140 may be withdrawn until the positioning element 146 contacts the distal end 24 of the introducer sheath 20, which may provide a first tactile feedback to the user (i.e., that the positioning element 146 has contacted the introducer sheath 20, e.g., based upon the increased weight and/or resistance to proximal movement). The positioning member 140 may be withdrawn further until the positioning element 146 contacts the wall of the vessel 94 and resists further withdrawal, thereby providing a second tactile feedback. The introducer sheath 20 may be pulled proximally by the positioning element 146 as the positioning member 120 is withdrawn, e.g., until the distal end 24 of the introducer sheath 20 is withdrawn from the vessel 94 into the puncture 90, as shown in
Proximal tension may be applied and/or maintained on the positioning member 140 to hold the positioning element 146 against the wall of the vessel 94, e.g., to seal the puncture 90 from the vessel 94 and/or prevent further removal of the positioning member 140. The proximal tension may be maintained manually or using a tensioner device (not shown) to provide temporary hemostasis, e.g., during the subsequent steps. Exemplary tension devices are disclosed in co-pending application Ser. No. 10/806,952, filed Mar. 22, 2004, the entire disclosure of which is expressly incorporated herein by reference.
Turning to
Thereafter, the cartridge 120 may be retracted, e.g., by pulling proximally on the hub 123. Because the locking element 150 has coupled the introducer sheath 20 to the cartridge 120, this action also withdraws the introducer sheath 20 from the puncture 90. As the cartridge 120 is retracted, the pusher member 130 may prevent substantial proximal movement of the sealant 2, thereby exposing the sealant 2 within the puncture 90, as shown in
When the sealant 2 is exposed within the puncture 90, the sealant 2 may be exposed to blood and/or other body fluids within the puncture 90. This exposure may cause the sealant 2 to absorb fluid and/or otherwise expand within the puncture 90, e.g., to provide hemostasis. If desired, once the sealant 2 is exposed within the puncture 90, the pusher member 130 may be advanced to compress or tamp the sealant 2, e.g., against the positioning element 146. Optionally, the pusher member 130 may include one or more distance markers (not shown) on or adjacent the proximal end 132, and the pusher member 130 may be advanced into the puncture 90 a desired distance, which may be confirmed by monitoring the distance markers.
Once the sealant 2 has been exposed for sufficient time and/or tamped by the pusher member 130, the positioning element 146 may be collapsed, and the positioning member 140 withdrawn from the vessel 94 and puncture 90, e.g., pulling the collapsed positioning element 146 through the sealant 2 and pusher member 130. The pusher member 130 may be maintained substantially stationary during withdrawal of the positioning member 140, e.g., to prevent migration and/or dislodgment of the sealant 2 within the puncture 90. Once the positioning member 140 is completely removed, the pusher member 130 may be removed from the puncture 90, leaving the sealant 2 within the puncture 90, as shown in
Optionally, after removing the positioning member 140, liquid hydrogel or other sealing compound, or other material may be delivered into the puncture 90, e.g., above and/or around the sealant 2, to assist in achieving hemostasis. For example, such material may be delivered via the lumen 136 of the pusher member 130 and/or by introducing another delivery device (not shown) into the puncture 90, e.g., after removing the pusher member 130.
Turning to
The sleeve 252 also has a passage 258 extending therethrough that allows the sleeve 252 to slidably receive the cartridge 120′ therethrough. The sleeve 252 may include one or more recesses and/or catches adjacent the passage 258, which may be engaged by a second set of detents 127′ on the cartridge 120,′ as described further elsewhere herein. The locking element 250 may be formed from one or more pieces of material, e.g., integrally formed from a single piece by injection molding, machining, and the like. The locking element 250 may be formed from plastic, metal, or composite material such that the sleeve 252 and extension 256 are substantially rigid, while the first detents 254 are resiliently deflectable between the expanded and collapsed positions.
As best seen in
Before use, the locking element 250 may be carried on the distal end 124′ of the cartridge 120,′ as shown in
The extension 256 and first detents 254 are sized to be distally advanced into the opening 27 in the introducer sheath 20, e.g., until the first detents 254 contact the abutment(s) 28, whereby further advancement compresses the first detents 254 radially inwardly as the first detents 254 pass through the abutment(s) 28. When the first detents 254 are advanced distally beyond the abutment(s) 28, the first detents 254 may resiliently resume the expanded position, as shown in
As shown in
The cartridge 120′ may be advanced sufficiently into the introducer sheath 20, e.g., until the distal end 124′ contacts the expanded positioning element 146 (not shown, see, e.g.,
Thus, when the second detents 127′ are expanded within the passage 258 and the first detents 252 are expanded beyond the abutment(s) 28, the introducer sheath 20 is coupled to the cartridge 120′ by the locking element 250. Subsequent movement of the cartridge 120,′ e.g., during withdrawal to expose the sealant 2, may cause corresponding movement of the introducer sheath 20 to expose the sealant 2 within the puncture 90, similar to the methods described above with respect to the embodiment of
Turning to
The extension 328 includes one or more barbs, catches, detents, or other features 327 extending radially outwardly from the extension 328. The detent(s) 327 may include a ramped and/or tapered distal surface 327a and a blunt proximal surface 327b, which may facilitate inserting the extension 328 at least partially into the locking element 350, similar to the second detents 127′ described elsewhere with reference to
The locking element 350 includes a sleeve, hub, or other carrier 352 and a nipple or extension 356 extending from the sleeve 352. The extension 356 includes a tapered distal end 353 including one or more flanges, catches, detents, or other features 354 that extending radially outwardly from the distal end 353. The distal end 353 may be sufficiently flexible to be expandable from a contracted position, shown in
The locking element 350 may be carried initially on the distal end 324 of the cartridge 320 with the distal end 353 in the contracted condition, as shown in
When the cartridge 320 is advanced distally through the sleeve 352 and into the lumen 26 of the introducer sheath 20, the cartridge 320 pushes the distal end 353 outwardly to the expanded position, as shown in
In the expanded position, the diameter of the detent(s) 354 on the distal end 353 is greater than that of the abutment(s) 28 in the introducer sheath 20. Thus, when the tube distal end 353 of the extension 356 is advanced into the hub 23 of the introducer sheath 20 beyond the abutment(s) 28 and directed to the expanded position, proximal movement of the locking element 350 causes the detent(s) 354 to engage the abutment 28, coupling the locking element 350 to the introducer sheath 20 and limiting proximal movement of the introducer sheath 20 separately from the locking element 350. When the locking element 350 is also coupled to the cartridge 320, subsequent proximal movement of the introducer sheath 20 is thus coupled to proximal movement of the cartridge 120, similar to the other embodiments herein.
The diameter of the sleeve 352 of the locking element 350 may be greater than that of the lumen 26 of the introducer sheath 20, such that the sleeve 352 cannot enter the lumen 26, thereby limiting advancement of the extension 356, distal end 353, and detent(s) 354 into the introducer sheath 20. Thus, the locking element 350 may be advanced distally into the introducer sheath 20 until the sleeve 352 abuts the hub 23 of the introducer sheath 20, preventing the extension 356 from advancing further into the introducer sheath 20. The cartridge 320 may still be advanced through the locking element 350 when the sleeve 352 contacts the hub 23 of the introducer sheath 20 to automatically expand the distal end 353 and detent(s) 354 of the locking element 350.
The locking element 350 may be coupled to the cartridge 320 when the cartridge 320 is advanced distally through the locking element 350 into the introducer sheath 20. For example, when the cartridge 320 is advanced into the introducer sheath, the locking element 350 may be advanced into the hub 23 of the introducer sheath until the distal end 353 and detent(s) 354 are disposed distally beyond the abutment(s) 28, as described above. When the sleeve 352 of the locking element 350 abuts the hub 23, the cartridge 320 may continue to be advanced through the locking element 350 until the detent(s) 327 on the cartridge 320 pass under the sleeve 352 and enter the passage 358 therein. The tapered distal end 327a may facilitate passing the detent(s) 327 under the sleeve 352, while the blunt proximal end 327b may abut the internal wall 359 to prevent subsequent disengagement of the locking element 350 from the cartridge 320. Optionally, the hub 323 of the cartridge 120 may be larger than the sleeve 352 of the locking element 350, thereby limiting distal movement of the cartridge 320 relative to the locking element 350.
Thus, when the detent(s) 327 on the cartridge 320 enter the passage 358 within the sleeve 352, subsequent proximal movement of the cartridge 320 causes corresponding proximal movement of the locking element 350. This couples subsequent movement of the introducer sheath 20 to that of the cartridge 320.
During use, the apparatus 301 may be used to deliver sealant 2 within a puncture 90, similar to other embodiments described elsewhere herein. For example, as shown in
As shown in
The cartridge 320 may continue to be advanced distally toward the positioning element 146 until the detent(s) 327 on the cartridge 320 pass under the sleeve 352 and enter the passage 358, as shown in
Subsequently, as shown in
Turning to
During use, when the cartridge 120 is advanced into an introducer sheath 20, as shown in
If it is desired to disengage the introducer sheath 20 from the cartridge 120, the collar 452 may be pulled proximally to collapse and extend the bellows 454 out of the hub 23 of the introducer sheath 20, as shown in
While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the scope of the appended claims.
This application is a continuation-in-part of co-pending application Ser. No. 12/098,380, filed Apr. 4, 2008, now U.S. Pat. No. 8,029,533, the entire disclosure of which is expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2115492 | Kober | Apr 1938 | A |
2365039 | Andresen | Dec 1944 | A |
3765419 | Usher | Oct 1973 | A |
4002173 | Manning | Jan 1977 | A |
4260077 | Schroeder | Apr 1981 | A |
4327709 | Hanson et al. | May 1982 | A |
4362150 | Lombardi, Jr. et al. | Dec 1982 | A |
4472542 | Nambu | Sep 1984 | A |
4540404 | Wolvek | Sep 1985 | A |
4655211 | Sakamoto et al. | Apr 1987 | A |
4664857 | Nambu | May 1987 | A |
4734097 | Tanabe | Mar 1988 | A |
4738658 | Magro et al. | Apr 1988 | A |
4801434 | Kido et al. | Jan 1989 | A |
4838280 | Haaga | Jun 1989 | A |
4838864 | Peterson | Jun 1989 | A |
4852568 | Kensey | Aug 1989 | A |
4890612 | Kensey | Jan 1990 | A |
5061274 | Kensey | Oct 1991 | A |
5087246 | Smith | Feb 1992 | A |
5104375 | Wolf et al. | Apr 1992 | A |
5104389 | Deem et al. | Apr 1992 | A |
5108421 | Fowler | Apr 1992 | A |
5192300 | Fowler | Mar 1993 | A |
5192302 | Kensey et al. | Mar 1993 | A |
5221259 | Weldon et al. | Jun 1993 | A |
5222974 | Kensey et al. | Jun 1993 | A |
5258042 | Mehta | Nov 1993 | A |
5259835 | Clark et al. | Nov 1993 | A |
5275616 | Fowler | Jan 1994 | A |
5290310 | Makower et al. | Mar 1994 | A |
5292332 | Lee | Mar 1994 | A |
5306254 | Nash et al. | Apr 1994 | A |
5320639 | Rudnick | Jun 1994 | A |
5324306 | Makower et al. | Jun 1994 | A |
5334216 | Vidal | Aug 1994 | A |
5370660 | Weinstein | Dec 1994 | A |
5383896 | Gershony | Jan 1995 | A |
RE34866 | Kensey et al. | Feb 1995 | E |
5391183 | Janzen et al. | Feb 1995 | A |
5409703 | McAnalley | Apr 1995 | A |
5413571 | Katsaros et al. | May 1995 | A |
5419765 | Weldon et al. | May 1995 | A |
5431639 | Shaw | Jul 1995 | A |
5437292 | Kipshidze et al. | Aug 1995 | A |
5437631 | Janzen | Aug 1995 | A |
5441517 | Kensey et al. | Aug 1995 | A |
5443481 | Lee | Aug 1995 | A |
5464396 | Barta et al. | Nov 1995 | A |
5486195 | Myers et al. | Jan 1996 | A |
5489278 | Abrahamson | Feb 1996 | A |
5514158 | Kanesaka | May 1996 | A |
5529577 | Hammerslag | Jun 1996 | A |
5550187 | Rhee | Aug 1996 | A |
5571181 | Li | Nov 1996 | A |
5580923 | Yeung | Dec 1996 | A |
5584815 | Pawelka et al. | Dec 1996 | A |
5591204 | Janzen et al. | Jan 1997 | A |
5591205 | Fowler | Jan 1997 | A |
5601602 | Fowler | Feb 1997 | A |
5626601 | Gershony et al. | May 1997 | A |
5637086 | Ferguson | Jun 1997 | A |
5643464 | Rhee | Jul 1997 | A |
5660849 | Polson et al. | Aug 1997 | A |
5700477 | Rosenthal | Dec 1997 | A |
5716375 | Fowler | Feb 1998 | A |
5718916 | Scherr | Feb 1998 | A |
5725498 | Janzen | Mar 1998 | A |
5725551 | Myers et al. | Mar 1998 | A |
5728122 | Leschinsky et al. | Mar 1998 | A |
5728132 | Van Tassel et al. | Mar 1998 | A |
5731368 | Stanley et al. | Mar 1998 | A |
5741223 | Janzen et al. | Apr 1998 | A |
5744153 | Yewey et al. | Apr 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5759193 | Burbank et al. | Jun 1998 | A |
5780044 | Yewey et al. | Jul 1998 | A |
5782860 | Epstein et al. | Jul 1998 | A |
5785679 | Abolfathi et al. | Jul 1998 | A |
5795331 | Cragg et al. | Aug 1998 | A |
5814016 | Valley | Sep 1998 | A |
5830130 | Janzen et al. | Nov 1998 | A |
5836970 | Pandit | Nov 1998 | A |
5843124 | Hammerslag | Dec 1998 | A |
5868778 | Gershony | Feb 1999 | A |
5916236 | Muijs Van de Moer et al. | Jun 1999 | A |
5922009 | Epstein et al. | Jul 1999 | A |
5928266 | Kontos | Jul 1999 | A |
5941847 | Huber et al. | Aug 1999 | A |
5948429 | Bell | Sep 1999 | A |
5948829 | Wallajapet | Sep 1999 | A |
5951583 | Jensen et al. | Sep 1999 | A |
5951589 | Epstein et al. | Sep 1999 | A |
5957952 | Gershony | Sep 1999 | A |
5972375 | Truter | Oct 1999 | A |
5973014 | Funk | Oct 1999 | A |
6017359 | Gershony | Jan 2000 | A |
6022361 | Epstein et al. | Feb 2000 | A |
6027471 | Fallon et al. | Feb 2000 | A |
6045570 | Epstein et al. | Apr 2000 | A |
6048358 | Barak | Apr 2000 | A |
6051248 | Sawhney | Apr 2000 | A |
6056768 | Cates | May 2000 | A |
6056769 | Epstein et al. | May 2000 | A |
6063061 | Wallace | May 2000 | A |
6083522 | Chu | Jul 2000 | A |
6090130 | Nash et al. | Jul 2000 | A |
6117145 | Wood | Sep 2000 | A |
6152943 | Sawhney | Nov 2000 | A |
6162240 | Cates et al. | Dec 2000 | A |
6162241 | Coury et al. | Dec 2000 | A |
6165201 | Sawhney | Dec 2000 | A |
6179862 | Sawhney | Jan 2001 | B1 |
6223936 | Jeanbourquin | May 2001 | B1 |
6238412 | Dubrul et al. | May 2001 | B1 |
6271278 | Park | Aug 2001 | B1 |
6287323 | Hammerslag | Sep 2001 | B1 |
6296658 | Gershony | Oct 2001 | B1 |
6299597 | Buscemi et al. | Oct 2001 | B1 |
6302898 | Edwards et al. | Oct 2001 | B1 |
6325789 | Janzen | Dec 2001 | B1 |
6350274 | Li | Feb 2002 | B1 |
6368300 | Fallon et al. | Apr 2002 | B1 |
6371975 | Cruise et al. | Apr 2002 | B2 |
6379373 | Sawhney | Apr 2002 | B1 |
6458147 | Cruise et al. | Oct 2002 | B1 |
6464712 | Epstein et al. | Oct 2002 | B1 |
6475177 | Suzuki | Nov 2002 | B1 |
6514534 | Sawhney | Feb 2003 | B1 |
6562059 | Edwards et al. | May 2003 | B2 |
6566406 | Pathak | May 2003 | B1 |
6569185 | Ungs | May 2003 | B2 |
6605294 | Sawhney | Aug 2003 | B2 |
6608117 | Gvozdic | Aug 2003 | B1 |
6610026 | Cragg | Aug 2003 | B2 |
6613070 | Redmond et al. | Sep 2003 | B2 |
6626861 | Hart | Sep 2003 | B1 |
6626918 | Ginn | Sep 2003 | B1 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6689148 | Sawhney | Feb 2004 | B2 |
6699261 | Cates et al. | Mar 2004 | B1 |
6703047 | Sawhney | Mar 2004 | B2 |
6774151 | Malmgren | Aug 2004 | B2 |
6818008 | Cates | Nov 2004 | B1 |
6818018 | Sawhney | Nov 2004 | B1 |
6863924 | Ranganathan | Mar 2005 | B2 |
6887974 | Pathak | May 2005 | B2 |
6890342 | Zhu et al. | May 2005 | B2 |
6890343 | Ginn et al. | May 2005 | B2 |
6960617 | Omidian | Nov 2005 | B2 |
6994686 | Cruise et al. | Feb 2006 | B2 |
7009034 | Pathak | Mar 2006 | B2 |
7118578 | West et al. | Oct 2006 | B2 |
7316704 | Bagaoisan et al. | Jan 2008 | B2 |
7331979 | Khosravi | Feb 2008 | B2 |
7335220 | Khosravi | Feb 2008 | B2 |
7553319 | Bagaoisan et al. | Jun 2009 | B2 |
7572274 | Yassinzadeh | Aug 2009 | B2 |
7611479 | Cragg et al. | Nov 2009 | B2 |
7621936 | Cragg et al. | Nov 2009 | B2 |
7790192 | Sawhney et al. | Sep 2010 | B2 |
7806856 | Bagaoisan | Oct 2010 | B2 |
7850710 | Huss | Dec 2010 | B2 |
7955353 | Ashby et al. | Jun 2011 | B1 |
7993367 | Bagaoisan | Aug 2011 | B2 |
20010031948 | Cruise et al. | Oct 2001 | A1 |
20010046518 | Sawhney | Nov 2001 | A1 |
20010047187 | Milo et al. | Nov 2001 | A1 |
20010051813 | Hnojewyj | Dec 2001 | A1 |
20020015724 | Yang et al. | Feb 2002 | A1 |
20020062104 | Ashby et al. | May 2002 | A1 |
20020072767 | Zhu | Jun 2002 | A1 |
20020106409 | Sawhney et al. | Aug 2002 | A1 |
20020111392 | Cruise | Aug 2002 | A1 |
20020111651 | Ungs | Aug 2002 | A1 |
20020188319 | Morris et al. | Dec 2002 | A1 |
20020193808 | Belef | Dec 2002 | A1 |
20030008831 | Yang et al. | Jan 2003 | A1 |
20030012734 | Pathak | Jan 2003 | A1 |
20030051735 | Pavcnik et al. | Mar 2003 | A1 |
20030088269 | Ashby | May 2003 | A1 |
20030088271 | Cragg et al. | May 2003 | A1 |
20030109899 | Fisher | Jun 2003 | A1 |
20030135234 | Fisher et al. | Jul 2003 | A1 |
20030135235 | Fisher et al. | Jul 2003 | A1 |
20030135236 | Fisher et al. | Jul 2003 | A1 |
20030139770 | Fisher et al. | Jul 2003 | A1 |
20030139771 | Fisher et al. | Jul 2003 | A1 |
20030139772 | Fisher et al. | Jul 2003 | A1 |
20030139773 | Fisher et al. | Jul 2003 | A1 |
20030233120 | Akerfeldt | Dec 2003 | A1 |
20040010287 | Bonutti | Jan 2004 | A1 |
20040122350 | Zhong et al. | Jun 2004 | A1 |
20040143290 | Brightbill | Jul 2004 | A1 |
20040147016 | Rowley | Jul 2004 | A1 |
20040176798 | Epstein et al. | Sep 2004 | A1 |
20040236262 | McIntosh et al. | Nov 2004 | A1 |
20040267308 | Bagaoisan | Dec 2004 | A1 |
20050085852 | Ditter | Apr 2005 | A1 |
20050085855 | Forsberg | Apr 2005 | A1 |
20050267522 | Yassinzadeh et al. | Dec 2005 | A1 |
20050277980 | Yassinzadeh | Dec 2005 | A1 |
20060034930 | Khosravi | Feb 2006 | A1 |
20060100664 | Pai | May 2006 | A1 |
20060161188 | Kennedy et al. | Jul 2006 | A1 |
20060241579 | Kawaura | Oct 2006 | A1 |
20060253037 | Ginn | Nov 2006 | A1 |
20060253072 | Pai | Nov 2006 | A1 |
20070060950 | Khosravi | Mar 2007 | A1 |
20070088362 | Bonutti et al. | Apr 2007 | A1 |
20070231366 | Sawhney | Oct 2007 | A1 |
20080243182 | Bates et al. | Oct 2008 | A1 |
20080269800 | Spurchise et al. | Oct 2008 | A1 |
20090088793 | Bagaoisan et al. | Apr 2009 | A1 |
20100211000 | Killion et al. | Aug 2010 | A1 |
Number | Date | Country |
---|---|---|
0476178 | Mar 1992 | EP |
0482350 | Apr 1992 | EP |
0716833 | Jun 1996 | EP |
9222252 | Dec 1992 | WO |
9413210 | Jun 1994 | WO |
9428798 | Dec 1994 | WO |
9922646 | May 1999 | WO |
0014155 | Mar 2000 | WO |
0019912 | Apr 2001 | WO |
03009764 | Feb 2003 | WO |
03087254 | Oct 2003 | WO |
03004749 | Nov 2003 | WO |
03094749 | Nov 2003 | WO |
Entry |
---|
PCT International Search Report and Written Opinion for PCT/US2008/077406, Applicant: AccessClosure, Inc., Forms PCT/ISA/220, PCT/ISA/210, and PCT/ISA/237; dated Dec. 22, 2008, 17 pages. |
Office Actions and Responses for related U.S. Appl. No. 11/864,835, filed Sep. 28, 2007; First named Inventor: Celso J. Bagaoisan; dated Mar. 1, 2010-Feb. 4, 2011; 46 pages. |
Number | Date | Country | |
---|---|---|---|
20120053621 A1 | Mar 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12098380 | Apr 2008 | US |
Child | 13252061 | US |